RECRUITING

The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex

Talk to us

Conditions

Cannabidiol EffectsDriving Performance

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objectives/purpose of this study are to comprehensively investigate the effects of non-prescription CBD on driving performance, drowsiness, sedation, and cognitive function in a large sample of healthy adults aged 18-30 years, with additional characterization of effects by dose and by sex, using a rigorous RCT design which will naturally mitigate confounding factors.

Official Title

The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex

Quick Facts

Study Start:2025-04-30
Study Completion:2029-05-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06686914

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 30 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Possess a current drivers' license
  2. * Driven a motor vehicle at least once in the past 30 days
  3. * Able to read English
  4. * Test negative for all substances on a urine drug test and complete a test drive to ensure the absence of simulation sickness
  5. * Not taking any daily prescription medications (excluding birth control)
  6. * Not diagnosed with any serious chronic disease by a licensed healthcare provider (including but not limited to Alzheimer's and related dementias, Parkinson's disease or other neurodegenerative disorder, major depressive or anxiety disorder, schizophrenia or other serious mental illness, arrhythmias, cataracts, glaucoma, chronic obstructive pulmonary disease, diabetes, epilepsy, sleep apnea, and fibromyalgia)
  7. * Have an individual willing to drive them home after testing or be taken home by study staff after testing
  1. * Currently smoke, vape or use tobacco products, used CBD in the past 30 days
  2. * Used illegal drugs in the past 30 days (e.g., cocaine/crack, heroin, methamphetamine, 3,4-methylenedioxy-methamphetamine, inhalants, phencyclidine, lysergic acid diethylamide, psilocybin mushrooms, or marijuana)
  3. * Are pregnant or lactating at time of study

Contacts and Locations

Study Contact

Toni M Rudisill, PhD
CONTACT
3042930687
trudisill@hsc.wvu.edu

Principal Investigator

Toni M Rudisill, PhD
PRINCIPAL_INVESTIGATOR
West Virginia University

Study Locations (Sites)

West Virginia University
Morgantown, West Virginia, 26506
United States

Collaborators and Investigators

Sponsor: West Virginia University

  • Toni M Rudisill, PhD, PRINCIPAL_INVESTIGATOR, West Virginia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-30
Study Completion Date2029-05-01

Study Record Updates

Study Start Date2025-04-30
Study Completion Date2029-05-01

Terms related to this study

Additional Relevant MeSH Terms

  • Cannabidiol Effects
  • Driving Performance